azilsartan medoxomil
Ligand id: 6900
Name: azilsartan medoxomil
View more information in the IUPHAR Pharmacology Education Project: azilsartan medoxomil
Structure and Physico-chemical Properties
|
Molecular properties generated using the CDK |
|||||||||||||||||||
Classification  |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (FDA (2011)) |
| Is prodrug? | Yes |
| Active form | azilsartan |
| IUPAC Name |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
| International Nonproprietary Names |
|
| INN number | INN |
| 8874 | azilsartan medoxomil |
| Synonyms |
| Edarbi® | TAK 491 |
| Comments |
| Azilsartan medoxomil is metabolised into the active form azilsartan. The azilsartan ligand page (accessed via the link above) contains more details of the drug's clinical use and mechanistic action. The marketed brand, Edarbi®, contains azilsartan medoxomil potassium (PubChem CID 23699544). |
| Database Links |
|
| CAS Registry No. | 863031-21-4 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL2028661 |
| DrugBank Ligand | DB08822 |
| GtoPdb PubChem SID | 178103482 |
| PubChem CID | 11238823 |
| Search Google for chemical match using the InChIKey | QJFSABGVXDWMIW-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | QJFSABGVXDWMIW |
| Search PubMed clinical trials | azilsartan medoxomil |
| Search PubMed titles | azilsartan medoxomil |
| Search PubMed titles/abstracts | azilsartan medoxomil |
| Search UniChem for chemical match using the InChIKey | QJFSABGVXDWMIW-UHFFFAOYSA-N |
| Search UniChem for chemicals with the same backbone | QJFSABGVXDWMIW |
| Wikipedia | Azilsartan |
